 |
Articles: Stomach/GI |
Prior Articles
Oral administration of mesalazine protects against mucosal injury and permeation in dextran sulfate sodium-induced colitis
Scandinavian Journal of Gastroenterology, 11/06/09
Timing of Myelosuppression During Thiopurine Therapy for Inflammatory Bowel Disease: Implications for Monitoring Recommendations
Clinical Gastroenterology and Hepatology, 11/04/09 Xenobiotic-Sensing Nuclear Receptors CAR and PXR as Drug Targets in Cholestatic Liver Disease
Current Drug Targets, 11/03/09 In Vitro Hepatic Metabolism Explains Higher Clearance of Voriconazole in Children versus Adults: Role of CYP2C19 and FMO3
Drug Metabolism and Disposition, 11/03/09 Influence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease
Gastroenterology, 10/28/09 Sustained virological response in a patient with chronic hepatitis C treated by monotherapy with the NS3-4A protease inhibitor telaprevir
Journal of Clinical Virology, 10/28/09 Methotrexate for maintenance of remission in Crohn's disease
Cochrane Reviews, 10/27/09 NSAID switching and short-term gastrointestinal outcome rates after the withdrawal of rofecoxib
Pharmacoepidemiology and Drug Safety, 10/27/09 Updates in Nonprescription Therapy for Heartburn and GERD
U.S. Pharmacist, 10/27/09
Free full text
Monotherapy versus combination therapy for the treatment of chronic hepatitis B
Expert Opinion on Investigational Drugs, 10/26/09 Pancreatic enzymes for chronic pancreatitis
Cochrane Reviews, 10/26/09 Bioequivalence among three methods of administering pantoprazole granules in healthy subjects
American Journal of Health-System Pharmacy, 10/26/09 Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders
Hepatology, 10/26/09 Influence of cyclooxygenase inhibitors on the function of the prostaglandin transporter OATP2A1 expressed in human gastroduodenal mucosa
Journal of Pharmacology and Experimental Therapeutics, 10/26/09 Anti-Egfr Therapy in Colorectal Cancer: How to Choose The Right Patient
Current Drug Targets, 10/23/09 Safety profile of dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed release formulation: global clinical trial experience
Alimentary Pharmacology and Therapeutics, 10/23/09 Neonatal Peritoneal Candidiasis Successfully Treated with Anidulafungin Add-On Therapy
Annals of Pharmacotherapy, 10/22/09 A Pilot Study Using Simvastatin in the Treatment of Nonalcoholic Steatohepatitis: A Randomized Placebo-controlled Trial
Journal of Clinical Gastroenterology, 10/22/09 Visceral fat area is an Independent Predictive Biomarker of Outcome after First-Line Bevacizumab-Based Therapy in Metastatic Colorectal Cancer
Gut, 10/22/09 Exclusive Author Commentary Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomized, placebo-controlled, double-blind trial
Gut, 10/22/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
|
|